Croda International (LON:CRDA) Given New GBX 3,100 Price Target at Berenberg Bank

Croda International (LON:CRDA) had its price objective reduced by research analysts at Berenberg Bank from GBX 3,800 ($50.38) to GBX 3,100 ($41.10) in a report issued on Tuesday, Marketbeat.com reports. The brokerage currently has a “buy” rating on the stock. Berenberg Bank’s price objective indicates a potential upside of 19.20% from the company’s previous close.

A number of other research analysts have also recently issued reports on the company. Citigroup lowered their price objective on Croda International from GBX 3,550 ($47.07) to GBX 3,300 ($43.75) and set a “neutral” rating for the company in a research note on Tuesday, April 29th. JPMorgan Chase & Co. upgraded shares of Croda International to an “overweight” rating in a research note on Wednesday.

Croda International Stock Up 0.1%

Shares of LON:CRDA opened at GBX 2,600.73 ($34.48) on Tuesday. The company has a current ratio of 2.72, a quick ratio of 2.25 and a debt-to-equity ratio of 30.90. The stock’s 50-day moving average price is GBX 2,985.88 and its 200-day moving average price is GBX 3,033.44. The stock has a market capitalization of £3.64 billion, a P/E ratio of 22.35, a price-to-earnings-growth ratio of 1.40 and a beta of 0.74. Croda International has a 12-month low of GBX 2,545 ($33.74) and a 12-month high of GBX 4,335 ($57.48).

Croda International (LON:CRDA) last posted its earnings results on Tuesday, July 29th. The company reported GBX 72.20 ($0.96) earnings per share (EPS) for the quarter. Croda International had a return on equity of 6.96% and a net margin of 9.98%. On average, equities analysts anticipate that Croda International will post 181.8307268 earnings per share for the current year.

Insider Buying and Selling at Croda International

In other Croda International news, insider Stephen Oxley bought 3,762 shares of the firm’s stock in a transaction dated Tuesday, July 29th. The shares were purchased at an average cost of GBX 2,671 ($35.42) per share, for a total transaction of £100,483.02 ($133,231.26). Also, insider Tom Brophy bought 54 shares of the company’s stock in a transaction dated Thursday, May 29th. The stock was bought at an average price of GBX 3,070 ($40.71) per share, with a total value of £1,657.80 ($2,198.09). Insiders purchased a total of 5,046 shares of company stock valued at $13,930,982 in the last three months. 0.93% of the stock is currently owned by corporate insiders.

Croda International Company Profile

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.